跳至主要内容
临床试验/NL-OMON46077
NL-OMON46077已完成不适用

MRI based prognostic biomarkers for treatment success of Minimal invasive treatment for Uterine Fibroids with Magnetic Resonance guided High Intensity Focused Ultrasound (MR-HIFU) - MASS II

Isala Klinieken0 个研究点目标入组 75 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients diagnosed with a symptomatic uterine fibroid (based on anamnesis, physical examination and vaginal ultrasonography), eligible for MR-HIFU treatment.

排除标准

  • - Post menopausal patients
  • - Pregnant patients
  • - Calcified fibroids
  • - Severe abdominal obesity
  • - MRI contra indications
  • - Funaki type 3 uterine fibroid
  • - Uterine fibroid close to sciatic nerve of sacrum, interpostion of bowel or ovary.
  • - Uterine fibroid diameter < 1 cm or > 10 cm
  • - Distance skin - uterine fibroid > 10 cm

研究者

发起方
Isala Klinieken

相似试验

MRI based prognostic biomarkers for treatment... | 临床试验